Market Miscellany Overhaul: Robotics SPAC Mergers and Biotech NDA SubmissionsGlobal Report·10 hours agoCCXI+7.58%MNPR-2.89%
HC Wainwright Has Positive Outlook of MNPR FY2027 EarningsMarket Beat·Jul 24 at 06:27 AMMNPR-2.89%JPM+0.15%
Maldonado Reiterates Buy on Monopar as ALXN1840 NDA Progress and Robust Clinical Data Drive Price Target Increase from $105 to $125Tip Ranks·Jul 22 at 10:15 AMMNPR-2.89%
Monopar starts rolling FDA NDA submission for ALXN1840 in Wilson diseasePUBT·Jul 22 at 07:01 AMMNPR-2.89%
Biotech Stocks At 52-Week Highs - XNCR, COAG, MNPR, SOPH, ACRSrttnews·Jul 21 at 02:45 AMMNPR-2.89%SOPH-1.77%
Biotech Stocks At 52-Week Highs: TRAX, BBIO, MNPR, TXG, MPLTrttnews·Jul 10 at 07:21 AMTRAX-8.00%MPLT+21.96%
Monopar Therapeutics director Nicole Sweeny files initial beneficial ownership statementPUBT·Jun 30 at 03:58 PMMNPR-2.89%
Monopar says FDA grants rare pediatric disease designation for ALXN1840 in Wilson diseasePUBT·Jun 30 at 07:02 AMMNPR-2.89%
